Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results89% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (4)
Early P 1 (1)
P 1 (5)
P 2 (1)
P 3 (1)

Trial Status

Completed8
Recruiting3
Unknown3
Not Yet Recruiting1
Withdrawn1
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06065670Phase 1Not Yet RecruitingPrimary

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT06573723Recruiting

Institutional Registry of Rare Diseases

NCT03268239Not ApplicableCompleted

Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

NCT04539002Phase 1Completed

Aerobic Exercise for Remyelination in Multiple Sclerosis

NCT06985303Early Phase 1Withdrawn

Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia

NCT06677710Phase 1Suspended

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

NCT05792176Not ApplicableCompleted

Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study

NCT03562975Completed

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

NCT06494228Recruiting

Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis

NCT04762342Not ApplicableUnknown

Power Training in Older Multiple Sclerosis Patients

NCT05834855Phase 3Recruiting

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

NCT05605951UnknownPrimary

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

NCT05199363Not ApplicableUnknown

Pediatric Patient Experience on a Diagnostic Path

NCT04837651Completed

Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab

NCT01963650Terminated

Natural History Study of Children With Metachromatic Leukodystrophy

NCT00283023Phase 1CompletedPrimary

Oligodendrocyte Progenitor Cell Culture From Human Brain

NCT01056471Phase 1Completed

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis

NCT00001287Phase 2CompletedPrimary

Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Showing all 18 trials

Research Network

Activity Timeline